Bruker, a provider of high-performance scientific instruments and solutions for molecular and materials research, and Norwegian University of Science and Technology (NTNU) have signed a research collaboration, under which Bruker has installed two nuclear magnetic resonance (NMR) spectrometers for metabolic profiling at the new MR Metabolomics Laboratory at the NTNU hospital campus in Trondheim.
The new NMR systems will enable scientists at NTNU’s Faculty of Medicine, working in partnership with clinicians at St. Olavs University Hospital, to jointly develop, optimize and implement NMR cancer diagnostics and prognostic modeling.
Researchers will use the NMR instrumentation for rapid, high-throughput analyses, aiming for characterisation, treatment planning and monitoring of cancer patients.
The ultimate goal is to investigate whether this methodology can provide clinicians with more detailed diagnostic information that can improve treatment for an individual patient.
Bruker director of NMR Applications in Germany Manfred Spraul said bringing metabolic profiling into a hospital setting with long traditions for developing and integrating new medical technology is a great start for innovations that potentially can improve patient care and reduce cost.